Kids' painkiller study aims for safer dosing
NCT ID NCT02044497
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how children aged 0-6 process the painkiller oxycodone after surgery. Researchers will measure drug levels in the blood and check certain genes that affect how the drug is broken down. The goal is to understand why some children may have more side effects or need different doses. About 68 children having specific surgeries will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- oral oxycodone
- What this could lead to
- If successful, this could help doctors give safer, more effective pain relief to children after surgery by tailoring doses based on genetics.
- What could go wrong
- This is a small, single-center study that only observes drug levels and genetics—it won't directly change treatment yet. Results may not apply to all children or surgeries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC SURGICAL PATIENT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children Hospital
Boston, Massachusetts, 02115, United States